Appeal No. 2002-1630 Page 2 Application No. 09/175,713 5. A composition comprising an isolated polynucleotide encoding an amino-terminal-modified chemokine, wherein the amino-terminal-modified chemokine comprises at least one methionine at least one aminooxypentane residue or at least one GroHEK peptide covalently attached to the amino terminus of the chemokine, and wherein the amino-terminal-modified chemokine is derived from a chemokine selected from the group consisting of SDF-lI, SDF-1J, IP-10, Mig, GROI, GROJ, GROK, interleukin-8, PF4, ENA-78, GCP-2, PBP, CTAP-III, J-thromboglobulin, NAP-2, C10, DC-CKI, CKIl, CKI2, MCP-1, MCP-2, MCP-3, MCP-4, MIP-lI, MIP-1J, lymphotactin, ATAC, eotaxin, eotaxin-2, I-309, HCC-1, HCC-2, HCC3, LARC/MIP-3I, MIP-3J, PARC, TARC, 6Ckine, ELC, SLC, CKJ4, CKJ6, CKJ7, CKJ8, CKJ9, CKJ11, CKJ12, CKJ13, and CX3C. 6. The composition of claim 1 wherein the polynucleotide is selected from the group consisting of: (a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 6; (b) a polynucleotide comprising the nucleotide sequence of the protein-coding sequence of the polynucleotide encoding met- hDSF-1I deposited under accession number ATCC 98506; (c) a polynucleotide encoding an amino-terminal-modified chemokine comprising the amino acid sequence of SEQ ID NO: 10; (d) a polynucleotide encoding a protein comprising an amino- terminal fragment of the amino acid sequence of SEQ ID NO: 10; (e) a polynucleotide comprising a nucleotide sequence complementary to any one of the polynucleotides specified in (a)- (d) above; and (f) a polynucleotide capable of hybridizing at either (i) 4xSSC at 65°C or (ii) 50% formamide and 4XSSC at 42°C, to any one of the polynucleotides specified in (a)-(e) above. The examiner relies on the following reference: Proudfoot et al. (Proudfoot), ”Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist,” J. Bio. Chem., Vol. 271 No. 5, pp.2599-2603 (1996)Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007